Express News | Aeterna Zentaris Completes Phase 3 DETECT-Trial For Macimorelin In Diagnosing Childhood Onset Growth Hormone Deficiency; Top-Line Data And Full Study Results Expected In Q3 2024

BenzingaJun 13 09:19 ET

News On Ceapro Inc. (CZO.V) Now Under AEZS.T

News On Ceapro Inc. (CZO.V) Now Under AEZS.T

Dow JonesJun 7 17:08 ET

Shareholder Alert: Ademi LLP Investigates Whether Aeterna Zentaris Inc.'s Transaction With Ceapro Was Fair to Shareholders

MILWAUKEE, June 7, 2024 /PRNewswire/ -- Ademi LLP is investigating Aeterna (Nasdaq: AEZS) for possible breaches of fiduciary duty and other violations of law in its transaction with Ceapro. Click her

PR NewswireJun 7 03:18 ET

Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to Be Announced in Coming Weeks and Details of AGM Expected to Be Announced Shortly

09:25 AM EDT, 06/03/2024 (MT Newswires) -- Aeterna and Ceapro Brief: Cos Complete Merger Transaction; New Name Expected to be Announced in Coming Weeks and Details of AGM Expected to be Announced Shor

MT NewswiresJun 3 09:25 ET

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris and Ceapro Complete Merger Transaction

Dow JonesJun 3 09:15 ET

Aeterna Zentaris Seeks Meeting Delay for Merger

TipRanksMay 30 03:00 ET